| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| R&D Expense | $537K | -80.2% |
| SG&A Expense | $17.9M | -27.2% |
| Operating Income | -$189.0M | -131.5% |
| Income Tax | $1K | — |
| Net Income | -$178.0M | -120.7% |
| EPS (Basic) | -$1.08 | -28.6% |
| EPS (Diluted) | -$1.08 | -28.6% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $93K | -58.0% |
| Current Assets | $1.0M | -47.6% |
| Total Assets | $8.2M | -95.0% |
| Current Liabilities | $29.2M | -3.8% |
| Total Liabilities | $29.6M | -5.0% |
| Stockholders' Equity | -$21.3M | -116.2% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.9M | +28.2% |
| Capital Expenditures | $70K | +0.0% |
| Investing Cash Flow | -$500K | +60.3% |
| Financing Cash Flow | $8.4M | -20.3% |
| Free Cash Flow | -$7.9M | +28.0% |